TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.00$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Xilio Development Inc (XLO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 154 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XLO
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 36 158 140 121 222 196 178 157 139 112 92 78 – 83 90 75 71 104 134 134 155 163 154
49 – 21 21 143 125 106 203 181 163 142 124 93 78 64 – 69 78 63 60 93 124 124 145 154 145
-49 – – 19 141 120 100 198 177 159 139 120 93 75 60 – 34 75 61 55 89 122 104 138 150 136
49 – – 19 141 120 100 198 177 159 139 120 93 75 60 – 34 75 61 55 89 122 104 138 150 136
– – – – – – 0.4 0.4 0.4 – 0.3 0.3 0.2 0.2 – – 30 – – – – – – 5.0 – 6.0
– – 14 14 14 13 7.1 14 7.5 13 13 7.3 7.3 6.8 – – – – – – – – – – – –
– – – 42 35 38 257 36 30 34 31 34 27 25 25 – 57 56 54 53 93 127 142 119 91 82
– – 22 22 16 21 13 13 12 18 17 21 16 16 17 – 32 39 38 27 48 53 56 56 43 34
– – – 3.0 4.1 4.7 0.8 0.9 3.3 4.2 6.8 7.6 7.6 8.1 6.0 – 1.1 1.1 1.2 1.2 1.2 1.3 1.3 1.3 1.4 1.4
– – 5.4 5.4 2.6 8.4 3.8 3.1 2.3 1.4 1.8 3.1 2.0 0.9 1.5 – 0.7 1.3 1.0 2.6 2.3 4.1 2.3 3.2 1.1 2.3
– – – 7.4 – 5.5 9.6 9.6 8.0 6.4 4.8 3.2 1.5 – – – – – – – – – – – – –
39 – – -5.3 124 102 -136 185 166 144 126 106 85 67 52 – 26 33 21 18 11 7.1 -8.1 35 73 72
– – -85 -85 -102 -125 -141 -161 -182 -207 -227 -249 -272 -291 -308 – -343 -357 -371 -384 -397 -413 -429 -419 -428 -435
0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.4 2.0 2.0 2.0 27 27 27 2.0 28 2.0 3.1 4.5 4.6 5.3 3.7 10 13 16 19

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?